Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Feihe is a leading producer of infant milk formula and adult nutrition products, primarily serving the Chinese market. The company distinguishes itself through extensive research into the composition of Chinese breast milk to develop formulas that are "more suitable" for Chinese infants. Its flagship product lines, including the Astrobaby and Organic series, leverage advanced nutritional components like OPO structural fats and lactoferrin. Feihe operates a fully integrated vertical cluster model that spans forage grass cultivation, dairy farming, and high-tech manufacturing. Beyond infant formula, the company has expanded into adult nutrition and dietary supplements through the acquisition of Vitamin World. China Feihe is publicly traded on the Hong Kong Stock Exchange and maintains a significant R&D presence in both China and North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Feihe.